Here are the 424B prospectus supplements from CitroTech Inc. (CITR) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow CITR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CITR filings page.
CitroTech Inc. (CITR) is offering 2,240,000 shares of common stock at $2.50 per share in a firm-commitment offering, for $5.6 million in gross proceeds. The company estimates net proceeds of approximately $5.0 million after underwriting discounts, commissions and estimated offering expenses, for working capital and general corporate purposes. Underwriters have a 45-day option to purchase up to 336,000 additional shares; full exercise would bring the offering to 2,576,000 shares and estimated net proceeds to approximately $5.8 million.
CitroTech sells specialty fire-inhibitor products and reports 31 issued patents and 56 patent applications pending. Its 50/50 joint venture with Hexion, formed in April 2026, is intended to commercialize products for lumber and wood applications. For the six months ended June 30, 2026, the company reported a $10.1 million net loss, compared with approximately $22.8 million in the prior-year period. As of June 30, 2026, its accumulated deficit was $123.3 million. CitroTech also disclosed material weaknesses in financial-reporting controls involving segregation of duties and accounting processes.
CitroTech Inc. registers up to 8,068,569 shares of Common Stock for resale by identified selling stockholders under Registration No. 333-293534. The Company will not receive proceeds from resale; it may receive proceeds if outstanding warrants are exercised. Shares outstanding after this offering are shown as 27,218,803 shares.
The resale pool includes shares issuable on conversion of Series C preferred stock, shares issuable upon exercise of warrants, and shares issuable upon conversion of convertible debt. The prospectus discloses recent operating losses and a net loss of $36,837,643 for the year ended December 31, 2025.